Tentolouris A, Eleftheriadou I, Athanasakis K, et al
Paul Zimmerman/Shutterstock I'm in bed and my son's like, Can you play tag? she recalled
The FDA originally approved Rybelsus in 2019 to improve glycemic control in adults with type 2 diabetes
GLP-1 tapering and long-term weight management If youre taking a GLP-1 for type 2 diabetes, you will likely stay on your maintenance dose unless your doctor recommends otherwise
I believe that the contributions that these new findings can make, in some cases, to the comorbidities associated with diabetes and obesity and, in others, as neuroprotectors against neurological diseases or psychiatric disorders, are really important
Thats why we offer ongoing follow-up and open communication with our patients, not just a prescription and a goodbye